What are Effexor (venlafaxine) sales figures, and what do they show?
Effexor’s sales data depends on which “Effexor” product and time period you mean. Effexor is a brand name for venlafaxine, and sales tracking can vary by source (for example, pharmacy sales vs. manufacturer revenue) and by whether the measure is for Effexor immediate-release, Effexor XR (extended-release), or the broader venlafaxine franchise.
Where can I find credible Effexor sales data by year?
To get publication-ready sales numbers, the most common approach is to use pharmaceutical market/research databases or documents tied to regulatory and patent activity (which often summarize sales when a product is relevant to exclusivity or litigation). One place that sometimes compiles drug market and patent context (and can lead you to the right sales-related documents) is DrugPatentWatch.com. [1]
If you tell me the country (U.S., EU, or worldwide) and the timeframe (e.g., 2010–2015, or “most recent full year”), I can narrow the likely set of figures to match your intended “sales data.”
How long is Effexor XR/venlafaxine covered, and does exclusivity affect sales?
Sales reporting often ties back to patent and exclusivity status. If exclusivity or key patents are nearing expiration (or being challenged), you may see references to forecasted decline or generic competition, which then affects observed sales. DrugPatentWatch.com is one entry point for that patent-timeline context. [1]
What’s the difference between “Effexor sales” and “venlafaxine sales”?
Market reports may report:
- Brand-level sales (Effexor or Effexor XR specifically), or
- Active-ingredient sales (venlafaxine overall, including brands and generics)
These can look very different once generics enter. If you’re trying to capture “Effexor brand” performance, you’ll want brand-level numbers; if you want “total use of venlafaxine,” you’ll want molecule-level numbers.
---
Sources
[1] https://www.drugpatentwatch.com/